1. Home
  2. RLMD vs HSON Comparison

RLMD vs HSON Comparison

Compare RLMD & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • HSON
  • Stock Information
  • Founded
  • RLMD 2004
  • HSON 1999
  • Country
  • RLMD United States
  • HSON United States
  • Employees
  • RLMD N/A
  • HSON N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • HSON Professional Services
  • Sector
  • RLMD Health Care
  • HSON Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • HSON Nasdaq
  • Market Cap
  • RLMD 22.0M
  • HSON 26.1M
  • IPO Year
  • RLMD N/A
  • HSON N/A
  • Fundamental
  • Price
  • RLMD $0.83
  • HSON $8.95
  • Analyst Decision
  • RLMD Hold
  • HSON
  • Analyst Count
  • RLMD 4
  • HSON 0
  • Target Price
  • RLMD $4.25
  • HSON N/A
  • AVG Volume (30 Days)
  • RLMD 840.1K
  • HSON 7.7K
  • Earning Date
  • RLMD 05-12-2025
  • HSON 05-13-2025
  • Dividend Yield
  • RLMD N/A
  • HSON N/A
  • EPS Growth
  • RLMD N/A
  • HSON N/A
  • EPS
  • RLMD N/A
  • HSON N/A
  • Revenue
  • RLMD N/A
  • HSON $138,031,000.00
  • Revenue This Year
  • RLMD N/A
  • HSON $0.80
  • Revenue Next Year
  • RLMD N/A
  • HSON $8.09
  • P/E Ratio
  • RLMD N/A
  • HSON N/A
  • Revenue Growth
  • RLMD N/A
  • HSON N/A
  • 52 Week Low
  • RLMD $0.24
  • HSON $8.49
  • 52 Week High
  • RLMD $4.47
  • HSON $19.70
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 72.41
  • HSON 41.21
  • Support Level
  • RLMD $0.65
  • HSON $8.76
  • Resistance Level
  • RLMD $0.77
  • HSON $9.50
  • Average True Range (ATR)
  • RLMD 0.10
  • HSON 0.42
  • MACD
  • RLMD 0.02
  • HSON -0.03
  • Stochastic Oscillator
  • RLMD 86.00
  • HSON 21.80

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: